Healthcare Contract Research Organization Market To Reach $105.73 Billion By 2033

Healthcare Contract Research Organization Market Growth & Trends

The global healthcare contract research organization market size is expected to reach USD 105.73 billion by 2033, registering a CAGR of 7.50% from 2026 to 2033, according to a new report by Grand View Research, Inc. The increasing cost of drug development is expected to drive market demand over the forecast period. Also, rising clinical trials cost and challenges pertaining to patient recruitment have led biopharmaceutical companies to turn to regions like Central and Eastern Europe, Asia Pacific, Latin America, and the Middle East for cost savings and quick patient recruitment.

In addition, growing pressure on industry players to follow stringent timelines has increased the demand for outsourcing research activities to contract research organizations(CRO)s. Some government organizations are also outsourcing their clinical trial activities so that they can carry out clinical trials with the required infrastructure and expertise and minimize their cost and timelines.

The CRO market was temporarily affected by the ongoing pandemic, as it led to the closure of clinical trial sites. However, owing to the significant demand for treatments, the clinical trial sites were reopened with certain measures and precautions to avoid the spread of the virus. Moreover, the worldwide focus on finding a vaccine against coronavirus has had a significant impact on the development of vaccines & drugs for COVID-19. This is expected to have a positive impact on the market.

Over the past 5 years, the number of mergers and acquisitions significantly increased. Several large mergers have been witnessed since 2016 till 2023. Moreover, the trend of large transactions seems to be picking up since 2021, as in March 2022, M&B Sciences Inc, acquired Clara Health, which expanded M&B Sciences’ access to digital technology-based clinical trials. Moreover, in December 2021, Thermo Fisher announced the acquisition of pharmaceutical services giant PPD, and in February 2021, ICON plc announced the acquisition of PRA Health Sciences. An era of consolidation has been witnessed around analytical technologies and software solutions used in the biopharmaceutical and pharmaceutical companies’ services space. Hence, the aforementioned factors supported the market’s growth.

 Request a free sample copy or view report summary: Healthcare Contract Research Organization Market Report

Healthcare Contract Research Organization Market Report Highlights

• On the basis of type, the clinical segment held the largest market share in 2025, accounting for a revenue share of 75.41%. Segment growth is driven by the increasing outsourcing of clinical trials, the rising prevalence of chronic and rare diseases, and the growing demand for faster drug development.

• Clinical monitoring held the largest revenue share in 2025 due to the growing number of clinical trials and the rising demand for monitoring services. Outsourcing to CROs has increased over the past decade, driven by cost efficiency and specialized expertise.

• Oncology represented the largest segment in the market in 2025, driven by the rising global prevalence of cancer and the urgent need for innovative therapies.

• On the basis of molecules, the pharmaceutical segment accounted for the largest share in 2025. The pharmaceutical segment is further sub-segmented into small molecule and biologics. The growth of this segment is driven by the rising number of promising small molecules in the global therapeutic market and the increasing use of specialty medicines.

• The North America healthcare Contract Research Organization (CRO) industry held the largest revenue share of 40.18% in 2025. Market growth is driven by increasing numbers of clinical trials, high R&D spending, and the outsourcing of trials.

Healthcare Contract Research Organization Market Segmentation

Grand View Research has segmented the global healthcare contract research organization market on the basis of type, service, therapeutic area, molecule and region:

Healthcare Contract Research Organization Type Outlook (Revenue, USD Million, 2021 - 2033)

• Drug Discovery

  • Target Validation

  • Lead Identification

  • Lead Optimization

• Pre-Clinical

• Clinical

  • Phase I Trial Services

  • Phase II Trial Services

  • Phase III Trial Services

  • Phase IV Trial Services

Healthcare Contract Research Organization Service Outlook (Revenue, USD Million, 2021 - 2033)

• Project Management/Clinical Supply Management

• Data Management

• Regulatory/Medical Affairs

• Medical Writing

• Clinical Monitoring

• Quality Management/ Assurance

• Bio-statistics

• Investigator Payments

• Laboratory

  • Sterility Testing

  • Container/Closure Testing

  • Extractables and Leachable Testing

  • Environmental Monitoring (Including Microbiology Testing)

  • Disinfectant Efficacy Studies

  • Others

• Patient And Site Recruitment

• Technology

• Others

Healthcare Contract Research Organization Therapeutic Area Outlook (Revenue, USD Million, 2021 - 2033)

• Oncology

• CNS Disorders

• Infectious Diseases

• Immunological Disorders

• Cardiovascular Diseases

• Respiratory Diseases

• Diabetes

• Ophthalmology

• Pain Management

• Others

Healthcare Contract Research Organization Molecule Outlook (Revenue, USD Million, 2021 - 2033)

• Pharmaceutical

  • Small Molecules

  • Biologics

• Medical Device

Healthcare Contract Research Organization Regional Outlook (Revenue, USD Million, 2021 - 2033)

• North America

  • U.S.

  • Canada

  • Mexico

• Europe

  • UK

  • Germany

  • France

  • Italy

  • Spain

  • Denmark

  • Sweden

  • Norway

• Asia Pacific

  • Japan

  • China

  • India

  • Australia

  • Thailand

  • South Korea

• Latin America

  • Brazil

  • Argentina

• Middle East & Africa

  • South Africa

  • UAE

  • Saudi Arabia

  • Kuwait

  • Qatar

  • Oman

List of Key Players in the Healthcare Contract Research Organization Market

• ICON Plc

• Charles River Laboratories

• Syneos Health

• IQVIA Inc.

• GVK Biosciences Private Limited (Aragen)

• LabCorp

• Parexel International Corporation

• Thermo Fisher Scientific

• CTI Clinical Trial & Consulting

• PSI

• Medpace

• Ergomed

• WuXi AppTec

• Worldwide Clinical Trials

• Medidata Solutions, Inc

• Pharmaron GMBH

• SGS SA

• KCR S.A.

• Advanced Clinical Research Services, LLC

• Pharm-Olam, LLC (Allucent)